BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2324649)

  • 1. Identification of metabolites from peroxisomal beta-oxidation of prostaglandins.
    Diczfalusy U; Alexson SE
    J Lipid Res; 1990 Feb; 31(2):307-14. PubMed ID: 2324649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome.
    Diczfalusy U; Vesterqvist O; Kase BF; Lund E; Alexson SE
    J Lipid Res; 1993 Jul; 34(7):1107-13. PubMed ID: 8371058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
    Diczfalusy U; Kase BF; Alexson SE; Björkhem I
    J Clin Invest; 1991 Sep; 88(3):978-84. PubMed ID: 1885782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisomal chain-shortening of prostaglandin F2 alpha.
    Diczfalusy U; Alexson SE
    J Lipid Res; 1988 Dec; 29(12):1629-36. PubMed ID: 3244014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chain-shortening of prostaglandin F2 alpha by rat liver peroxisomes.
    Diczfalusy U; Alexson SE; Pedersen JI
    Biochem Biophys Res Commun; 1987 May; 144(3):1206-13. PubMed ID: 3472523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes.
    Sago T; Nakayama R; Okumura T; Saito K
    Biochim Biophys Acta; 1986 Dec; 879(3):330-8. PubMed ID: 3465372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.
    Schepers L; Casteels M; Vamecq J; Parmentier G; Van Veldhoven PP; Mannaerts GP
    J Biol Chem; 1988 Feb; 263(6):2724-31. PubMed ID: 3422639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
    Jedlitschky G; Huber M; Völkl A; Müller M; Leier I; Müller J; Lehmann WD; Fahimi HD; Keppler D
    J Biol Chem; 1991 Dec; 266(36):24763-72. PubMed ID: 1761571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2,4-dienoyl-coenzyme A reductase in peroxisomal beta-oxidation.
    Hiltunen JK; Kärki T; Hassinen IE; Osmundsen H
    J Biol Chem; 1986 Dec; 261(35):16484-93. PubMed ID: 2877988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of peroxisomal beta-oxidation system to the chain-shortening of N-(alpha-methylbenzyl)azelaamic acid in rat liver.
    Suzuki H; Mori K; Yamada J; Suga T
    Biochem Pharmacol; 1990 Jun; 39(12):1975-81. PubMed ID: 2353938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in circulating prostaglandin metabolites. Relevance for the assay of prostaglandin release.
    Granström E; Kindahl H
    Biochim Biophys Acta; 1982 Dec; 713(3):555-69. PubMed ID: 6960930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-dependent retention of prostaglandins in rat ileum.
    Bikhazi AB; Lakkis NM; Abu-Chehade KD
    J Pharm Sci; 1991 Dec; 80(12):1110-3. PubMed ID: 1815067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha.
    Chiabrando C; Valagussa A; Rivalta C; Durand T; Guy A; Zuccato E; Villa P; Rossi JC; Fanelli R
    J Biol Chem; 1999 Jan; 274(3):1313-9. PubMed ID: 9880501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total and peroxisomal oxidation of various saturated and unsaturated fatty acids in rat liver, heart and m. quadriceps.
    Reubsaet FA; Veerkamp JH; Trijbels JM; Monnens LA
    Lipids; 1989 Nov; 24(11):945-50. PubMed ID: 2615563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel metabolites of prostaglandin E2 formed by isolated rat hepatocytes.
    Hankin JA; Wheelan P; Murphy RC
    Arch Biochem Biophys; 1997 Apr; 340(2):317-30. PubMed ID: 9143337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of the peroxisomal beta-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNKO1, in rat liver.
    Yoshida Y; Yamada J; Watanabe T; Suga T; Takayama H
    Biochem Pharmacol; 1990 May; 39(10):1505-12. PubMed ID: 2337407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic aspects of peroxisomal beta-oxidation.
    Osmundsen H; Bremer J; Pedersen JI
    Biochim Biophys Acta; 1991 Sep; 1085(2):141-58. PubMed ID: 1892883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
    Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
    Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of intermediates in the peroxisomal beta-oxidation of linoleic acid.
    Diczfalusy U; Alexson SE; Sisfontes L; Olund J; Björkhem I
    Biochim Biophys Acta; 1990 Apr; 1043(2):182-8. PubMed ID: 2317529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
    Singh H; Beckman K; Poulos A
    J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.